UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Activité antitumorale d'analogues structuraux de la géogénine à fonction γ-lactone ou p-quinone

Pharmazie, 1986, Vol.41 (10), p.743-744

1986

Volltextzugriff (PDF)

Time-schedule dependency of S 16020, a new topoisomerase II inhibitor

Anti-cancer drugs, 1999-07, Vol.10 (6), p.597-604

1999

Volltextzugriff (PDF)

Multidrug resistance circumvention by a new triazinoaminopiperidine derivative S9788 in vitro: definition of the optimal schedule and comparison with verapamil

British journal of cancer, 1994-05, Vol.69 (5), p.868-874

1994

Volltextzugriff (PDF)

Synthesis of some naphthoxazine carbolactone derivatives with in vitro cytotoxic and antifungal activities

European journal of medicinal chemistry, 1991, Vol.26 (4), p.469-472

1991

Volltextzugriff (PDF)

Tamoxifen enhances the cytotoxic effects of the nitrosourea fotemustine. Results on human melanoma cell lines

European journal of cancer (1990), 1993, Vol.29 (16), p.2269-2273

1993

Volltextzugriff (PDF)

Reversal of inherent multidrug-resistance in primary human renal cell carcinoma cell cultures by S 9788

Anticancer research, 1993-07, Vol.13 (4), p.905

1993

Volltextzugriff (PDF)

Evaluation of the time-schedule dependency for the cytotoxic activity of the new vinca alkaloid derivative, S 12363 (Vinfosiltine)

European journal of cancer (1990), 1993, Vol.29 (13), p.1890-1894

1993

Volltextzugriff (PDF)

The Olivacine S16020 Enhances the Antitumor Effect of Ionizing Radiation without Increasing Radio-induced Mucositis

Clinical cancer research, 2001-07, Vol.7 (7), p.2091-2095

2001

Volltextzugriff (PDF)

Antitumor activity of the new vinca-alkaloid S 12363 alone or in combination with verapamil on a human multidrug resistant renal carcinoma xenograft

In vivo (Athens), 1993-09, Vol.7 (5), p.399

1993

Volltextzugriff (PDF)

Characterization of the pharmacological antitumor effects of S 12363, a new vinca alkaloid

Anticancer research, 1991-03, Vol.11 (2), p.975

1991

Volltextzugriff (PDF)

Enhancement of fotemustine (Muphoran®) cytotoxicity by amifostine in malignant melanoma cell lines

Anti-cancer drugs, 2002-02, Vol.13 (2), p.141-147

2002

Volltextzugriff (PDF)

Sequence-dependent cytotoxic effects of the combination of a new nitrosourea, fotemustine, with 5-fluorouracil plus folinic acid

Cancer chemotherapy and pharmacology, 1991-01, Vol.28 (6), p.448-454

1991

Volltextzugriff (PDF)

Activité antitumorale in vivo de l'hydroxy-5, dihydro-3,4 naphtalène carbolactone-1,8 et de ses dérivés

Pharmazie, 1988, Vol.43 (7), p.515-516

1988

Volltextzugriff (PDF)

Correlation of the electronic parameters with the antitumoral activity of 5-carbamoyloxy and 5-acyloxy naphthalene-1,8-carbolactones

Pharmazie, 1989-07, Vol.44 (7), p.507-508

1989

Volltextzugriff (PDF)

Antineoplastic activity of structural analogs of geogenine with a gamma-lactone or p-quinone function

Pharmazie, 1986-10, Vol.41 (10), p.743-744

1986

Volltextzugriff (PDF)

Preclinical antitumor activity of a new Vinca alkaloid derivative, S 12363

Cancer research (Chicago, Ill.), 1991-05, Vol.51 (9), p.2312-2318

1991

Volltextzugriff (PDF)

In vitro and in vivo circumvention of multidrug resistance by Servier 9788, a novel triazinoaminopiperidine derivative

Investigational new drugs, 1992-08, Vol.10 (3), p.137-148

1992

Volltextzugriff (PDF)

In vitro activity of S 9788 on a multidrug-resistant leukemic cell line and on normal hematopoietic cells-reversal of multidrug resistance by sera from phase I-treated patients

Cancer chemotherapy and pharmacology, 1995, Vol.36 (3), p.195-203

1995

Volltextzugriff (PDF)

In vitro pharmacological monitoring of phase I–II trials of S 9788. A multidrug resistance (MDR) reversing agent

European journal of cancer (1990), 1993, Vol.29, p.S114-S114

1993

Volltextzugriff (PDF)

In vitro activity of S 9788 on a multidrug-resistance leukemic cell line and on normal hematopoietic cells-reversal of multidrug resistance by sera from phase I-treated patients

Cancer chemotherapy and pharmacology, 1995, Vol.36 (3), p.195-203

1995

Volltextzugriff (PDF)

In vivo evidence of complete circumvention of vincristine resistance by a new triazinoaminopiperidine derivative S 9788 in P388/VCR leukemia model

Cancer chemotherapy and pharmacology, 1992, Vol.30 (6), p.491-494

1992

Volltextzugriff (PDF)

In vivo antitumor activity of 5-hydroxy 3,4-dihydro naphthalene 1,8-carbolactone and its derivatives

Pharmazie, 1988-07, Vol.43 (7), p.515-516

1988

Volltextzugriff (PDF)

Modulation of anthracycline accumulation and metabolism in rat hepatocytes in culture by three revertants of multidrug resistance

Cancer chemotherapy and pharmacology, 1994, Vol.35 (1), p.53-58

1994

Volltextzugriff (PDF)

Comparison of S 9788, a new modulating agent, to verapamil and cyclosporin in reversing multidrug resistance (MDR)

European journal of cancer (1990), 1993, Vol.29, p.S113-S113

1993

Volltextzugriff (PDF)

Diels-Alder Reactions between Dienamides and Quinones : Stereochemistry of the Cycloadditions and Cytotoxic Activity of the Adducts

Chemical and Pharmaceutical Bulletin, 1990/03/25, Vol.38(3), pp.688-691

1990

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(39)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(19)
Animals
(18)
Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Pharmacology. Drug Treatments
(13)
Antineoplastic Agents
(12)
Mice
(12)
Oncology
(11)
Tumor Cells, Cultured - Drug Effects
(10)
Cell Survival - Drug Effects
(9)
General Aspects
(9)
Pharmacology & Pharmacy
(8)
Tumor Cells, Cultured
(8)
Antineoplastic Agents - Pharmacology
(7)
Dose-Response Relationship, Drug
(7)
Drug Screening Assays, Antitumor
(7)
Verapamil - Pharmacology
(7)
Drug Synergism
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Activité antitumorale d'analogues structuraux de la géogénine à fonction γ-lactone ou p-quinone

Time-schedule dependency of S 16020, a new topoisomerase II inhibitor

Multidrug resistance circumvention by a new triazinoaminopiperidine derivative S9788 in vitro: definition of the optimal schedule and comparison with verapamil

Synthesis of some naphthoxazine carbolactone derivatives with in vitro cytotoxic and antifungal activities

Tamoxifen enhances the cytotoxic effects of the nitrosourea fotemustine. Results on human melanoma cell lines

Reversal of inherent multidrug-resistance in primary human renal cell carcinoma cell cultures by S 9788

Evaluation of the time-schedule dependency for the cytotoxic activity of the new vinca alkaloid derivative, S 12363 (Vinfosiltine)

The Olivacine S16020 Enhances the Antitumor Effect of Ionizing Radiation without Increasing Radio-induced Mucositis

Antitumor activity of the new vinca-alkaloid S 12363 alone or in combination with verapamil on a human multidrug resistant renal carcinoma xenograft

Characterization of the pharmacological antitumor effects of S 12363, a new vinca alkaloid

Enhancement of fotemustine (Muphoran®) cytotoxicity by amifostine in malignant melanoma cell lines

Sequence-dependent cytotoxic effects of the combination of a new nitrosourea, fotemustine, with 5-fluorouracil plus folinic acid

Activité antitumorale in vivo de l'hydroxy-5, dihydro-3,4 naphtalène carbolactone-1,8 et de ses dérivés

Correlation of the electronic parameters with the antitumoral activity of 5-carbamoyloxy and 5-acyloxy naphthalene-1,8-carbolactones

Antineoplastic activity of structural analogs of geogenine with a gamma-lactone or p-quinone function

Preclinical antitumor activity of a new Vinca alkaloid derivative, S 12363

In vitro and in vivo circumvention of multidrug resistance by Servier 9788, a novel triazinoaminopiperidine derivative

In vitro activity of S 9788 on a multidrug-resistant leukemic cell line and on normal hematopoietic cells-reversal of multidrug resistance by sera from phase I-treated patients

In vitro pharmacological monitoring of phase I–II trials of S 9788. A multidrug resistance (MDR) reversing agent

In vitro activity of S 9788 on a multidrug-resistance leukemic cell line and on normal hematopoietic cells-reversal of multidrug resistance by sera from phase I-treated patients

In vivo evidence of complete circumvention of vincristine resistance by a new triazinoaminopiperidine derivative S 9788 in P388/VCR leukemia model

In vivo antitumor activity of 5-hydroxy 3,4-dihydro naphthalene 1,8-carbolactone and its derivatives

Modulation of anthracycline accumulation and metabolism in rat hepatocytes in culture by three revertants of multidrug resistance

Comparison of S 9788, a new modulating agent, to verapamil and cyclosporin in reversing multidrug resistance (MDR)

Diels-Alder Reactions between Dienamides and Quinones : Stereochemistry of the Cycloadditions and Cytotoxic Activity of the Adducts

Suchergebnisse filtern